question: Compared to baseline what was the result of bevacizumab  on circulating endothelial cells (CECs) after 4 and 6 weeks?
context: In patients receiving bevacizumab plus lomustine combination therapy, patients had higher CECs after 4 weeks (P<0.001) and 6 weeks (P<0.001) of treatment compared with the baseline value.